Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation No phase listed Observational Accepts healthy volunteers

Hydration, Ergonomic Risk, and Fatigue Across Multiple PepsiCo Facilities

ClinicalTrials.gov ID: NCT07848256

Public ClinicalTrials.gov record NCT07848256. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Physically demanding occupations require high levels of energy expenditure, mental sharpness, and technical skills, and are often performed in extreme environments during hot/humid summer months. Previous research shows dehydration and heat stress can increase risk of heat-related illness, reduce cognitive function, and work capacity. The relationship between hydration status and occupational physical and environmental demands has yet to be fully understood and compared across occupations. This study will examine hydration, sweat profile, activity level and its association with ergonomic risk (high, moderate, and mild risk movement patterns performed during work) and fatigue to improve our understanding of the hydration needs of warehouse workers.

Study identification

NCT ID
NCT07848256
Recruitment status
Enrolling by invitation
Study type
Observational
Phase
Not listed
Lead sponsor
PepsiCo Global R&D
Industry
Enrollment
60 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2026 (Estimated)
Primary completion
Dec 2026 (Estimated)
Completion
Jan 2027 (Estimated)
Last update posted
Sep 29, 2026

2026 – 2027

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
2
Facility City State ZIP Site status
Orlando PBNA Bottling Facility Orlando Florida 32809 —
PepsiCo Beverages Tampa Florida 33612 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07848256, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07848256 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →